Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lagrange, E.
Right arrow Articles by Pollak, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lagrange, E.
Right arrow Articles by Pollak, P.
Related Collections
Right arrow Parkinson's disease/Parkinsonism
Right arrow Clinical trials Observational study (Cohort, Case control)
Right arrow Surgery/Stimulation

Neurology 2002;59:1976-1978
© 2002 American Academy of Neurology


Brief Communications

Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD

E. Lagrange, MD, P. Krack, MD PhD, E. Moro, MD PhD, C. Ardouin, MA, N. Van Blercom, MD, S. Chabardes, MD, A.L. Benabid, MD PhD and P. Pollak, MD

From the Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France.

Address correspondence and reprint requests to Dr. Paul Krack, Department of Clinical and Biological Neurosciences, Joseph Fourier University, BP 217 38043, Grenoble CEDEX 9, France; e-mail: paul.krack{at}ujf-grenoble.fr

In order to assess the impact of bilateral subthalamic nucleus (STN) stimulation in PD on quality of life, the PD Quality of Life questionnaire was assessed in 60 consecutive patients with PD before surgery and 12 months after surgery. All aspects of quality of life, including motor (+48%), systemic (+34%), emotional (+29%), and social (+63%) dimensions, significantly improved with long-term STN stimulation.




This article has been cited by other articles:


Home page
NeurologyHome page
M. Schupbach, M. Gargiulo, M. L. Welter, L. Mallet, C. Behar, J. L. Houeto, D. Maltete, V. Mesnage, and Y. Agid
Neurosurgery in Parkinson disease: A distressed mind in a repaired body?
Neurology, June 27, 2006; 66(12): 1811 - 1816.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
V Fraix, J-L Houeto, C Lagrange, C Le Pen, P Krystkowiak, D Guehl, C Ardouin, M-L Welter, F Maurel, L Defebvre, et al.
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 443 - 449.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Diamond and J Jankovic
The effect of deep brain stimulation on quality of life in movement disorders
J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1188 - 1193.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
V Fraix, P Pollak, E Moro, S Chabardes, J Xie, C Ardouin, and A L Benabid
Subthalamic nucleus stimulation in tremor dominant parkinsonian patients with previous thalamic surgery
J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 246 - 248.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Minguez-Castellanos, F Escamilla-Sevilla, M J Katati, J M Martin-Linares, M Meersmans, A Ortega-Moreno, and V Arjona
Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias?
J. Neurol. Neurosurg. Psychiatry, January 1, 2005; 76(1): 34 - 39.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M C Rodriguez-Oroz, I Zamarbide, J Guridi, M R Palmero, and J A Obeso
Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation
J. Neurol. Neurosurg. Psychiatry, October 1, 2004; 75(10): 1382 - 1385.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
D. J. Burn and A. I. Troster
Neuropsychiatric Complications of Medical and Surgical Therapies for Parkinson's Disease
J Geriatr Psychiatry Neurol, September 1, 2004; 17(3): 172 - 180.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.